Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

331
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
331
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

36
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
36
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

298
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
298
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

45
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
45
Hormonal Regulation01:33

Hormonal Regulation

32.8K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
32.8K
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

414
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
414

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dorsal onlay buccal mucosal graft urethroplasty in a female patient: a case report from Vietnam.

International journal of surgery case reports·2026
Same author

Clinical Triage of Individuals With Warning Symptoms of Imminent Cardiac Arrest.

Circulation. Arrhythmia and electrophysiology·2026
Same author

Personalizing Cardio-Kidney-Metabolic Therapy: Closer But Not There Yet.

Journal of the American Society of Nephrology : JASN·2026
Same author

Dynamic Risk Trajectories for Sudden Cardiac Arrest: The Role of Recurrent Cardiovascular Events.

Journal of the American Heart Association·2026
Same author

Atrial Fibrillation and Stroke Prevention and Management in Chronic Kidney Disease.

Clinical journal of the American Society of Nephrology : CJASN·2026
Same author

Cannabis Use among People Receiving Maintenance Hemodialysis with Chronic Pain.

Kidney360·2026

Related Experiment Video

Updated: May 16, 2025

Technical Refinement of a Bilateral Renal Ischemia-Reperfusion Mouse Model for Acute Kidney Injury Research
03:13

Technical Refinement of a Bilateral Renal Ischemia-Reperfusion Mouse Model for Acute Kidney Injury Research

Published on: November 3, 2023

2.1K

Moderate Kidney Dysfunction Independently Increases Sudden Cardiac Arrest Risk: A Community-Based Study.

Thien Tan Tri Tai Truyen1, Audrey Uy-Evanado1, Harpriya Chugh1

  • 1Center for Cardiac Arrest Prevention, Department of Cardiology, Smidt Heart Institute, Cedars-Sinai Health System, Los Angeles, CA, United States.

Medrxiv : the Preprint Server for Health Sciences
|March 31, 2025
PubMed
Summary

Moderate chronic kidney disease (CKD) is linked to a higher risk of sudden cardiac arrest (SCA) in adults. This finding highlights the importance of considering kidney function in cardiovascular risk assessments.

Keywords:
Chronic Kidney FailureCommunity-Based StudyRisk FactorSudden Cardiac Arrest

More Related Videos

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
07:52

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

20.3K
Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

16.2K

Related Experiment Videos

Last Updated: May 16, 2025

Technical Refinement of a Bilateral Renal Ischemia-Reperfusion Mouse Model for Acute Kidney Injury Research
03:13

Technical Refinement of a Bilateral Renal Ischemia-Reperfusion Mouse Model for Acute Kidney Injury Research

Published on: November 3, 2023

2.1K
A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
07:52

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

20.3K
Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

16.2K

Area of Science:

  • Nephrology
  • Cardiology
  • Epidemiology

Background:

  • Moderate kidney dysfunction is an independent risk factor for cardiovascular mortality.
  • Sudden cardiac arrest (SCA) accounts for a significant portion of mortality in chronic kidney disease (CKD) patients.

Purpose of the Study:

  • To investigate the association between moderate CKD and the risk of out-of-hospital SCA.
  • To determine if moderate renal dysfunction is an independent risk factor for SCA.

Main Methods:

  • A case-control study was conducted using data from a prospective, community-based investigation of out-of-hospital SCA.
  • Cases (SCA survivors) and controls (no history of SCA) aged 40-75 were analyzed, with moderate CKD defined as an eGFR of 30 to <60 mL/min/1.73 m².
  • A validation cohort was used to confirm the findings.

Main Results:

  • SCA cases exhibited a higher prevalence of moderate CKD (17.7%) compared to controls (14.7%).
  • Moderate CKD was identified as an independent risk factor for SCA (OR: 1.33, 95% CI: 1.03-1.72).
  • A decrease in eGFR below 90 mL/min/1.73 m² was associated with increased SCA risk, a finding consistent in the validation cohort.

Conclusions:

  • Moderate CKD is significantly associated with an increased risk of SCA in the general population.
  • The findings suggest that renal dysfunction should be considered in SCA risk stratification models.
  • Further research is warranted to integrate moderate renal dysfunction into SCA risk assessment strategies.